CUHK Inter-disciplinary Research Team Finds Novel Drug Candidate for Rare Neurological Diseases (English version)

6 Jun, 2016
Since 1998, Prof. Edwin Chan from CUHK School of Life Sciences has studied a group of rare neurological disorders and developed therapeutic interventions against these diseases. Prof. Chan’s team has discovered a drug candidate P3, a 13-amino acid peptide, which can neutralize toxic RNA and rescue neurodegeneration. A United States patent application protecting this technology has been allowed by the US Patent and Trademark Office. P3 has the potential to be developed into therapeutic usage giving hope to individuals who suffer from rare neuronal diseases. 

Please click here to watch the Chinese version. 

Categories / Series:

Tags:

Share to: